Literature DB >> 2108871

A competitive ELISA for the detection of group-specific antibodies to African horse sickness virus.

C Hamblin1, S D Graham, E C Anderson, J R Crowther.   

Abstract

A competition enzyme-linked immunosorbent assay (ELISA) has been developed for the rapid identification and quantification of antibodies against African horse sickness (AHS) in sera from solipeds. The data showed the ELISA to be sensitive, specific and reliable. More than 1600 sera from 37 different countries were examined and results compared with those obtained by agar gel immuno-diffusion (AGID) tests. In no case did any of 775 sera from countries where AHS has never been reported and where AHS vaccines are not used, record an ELISA titre greater than 4. A titre equal to or greater than 8 was considered positive. Using this criterion, 96.3% of sera tested in both assays were in agreement. Doubtful results by AGID (1.7%) were clearly defined in terms of positivity and negativity by ELISA. This ELISA is suited for the rapid laboratory confirmation of AHS and should be considered as a replacement for the traditional AGID test.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2108871      PMCID: PMC2271754          DOI: 10.1017/s0950268800059483

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  2 in total

1.  Comparison of competitive and indirect enzyme-linked immunosorbent assays for detection of bluetongue virus antibodies in serum and whole blood.

Authors:  A Afshar; F C Thomas; P F Wright; J L Shapiro; P T Shettigara; J Anderson
Journal:  J Clin Microbiol       Date:  1987-09       Impact factor: 5.948

2.  A single dilution enzyme-linked immunosorbent assay for the quantitative detection of antibodies to African horsesickness virus.

Authors:  R Williams
Journal:  Onderstepoort J Vet Res       Date:  1987-03       Impact factor: 1.792

  2 in total
  7 in total

1.  Antibodies to some pathogenic agents in free-living wild species in Tanzania.

Authors:  C Hamblin; E C Anderson; M Jago; T Mlengeya; K Hipji
Journal:  Epidemiol Infect       Date:  1990-12       Impact factor: 2.451

2.  The detection of African horse sickness virus antigens and antibodies in young Equidae.

Authors:  C Hamblin; E C Anderson; P S Mellor; S D Graham; P P Mertens; J N Burroughs
Journal:  Epidemiol Infect       Date:  1992-02       Impact factor: 2.451

3.  Antibodies in horses, mules and donkeys following monovalent vaccination against African horse sickness.

Authors:  C Hamblin; P S Mellor; S D Graham; H Hooghuis; R C Montejano; M A Cubillo; J Boned
Journal:  Epidemiol Infect       Date:  1991-04       Impact factor: 2.451

4.  Immune response of horses to inactivated African horse sickness vaccines.

Authors:  Marina Rodríguez; Sunitha Joseph; Martin Pfeffer; Rekha Raghavan; Ulrich Wernery
Journal:  BMC Vet Res       Date:  2020-09-01       Impact factor: 2.741

5.  Seroepidemiological study of African horse sickness virus in The Gambia.

Authors:  N Staeuber; B Fye; J Zinsstag; K C McCullough
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

6.  Real time RT-PCR assays for detection and typing of African horse sickness virus.

Authors:  Katarzyna Bachanek-Bankowska; Sushila Maan; Javier Castillo-Olivares; Nicola M Manning; Narender Singh Maan; Abraham C Potgieter; Antonello Di Nardo; Geoff Sutton; Carrie Batten; Peter P C Mertens
Journal:  PLoS One       Date:  2014-04-10       Impact factor: 3.240

7.  Assessment of reproducibility of a VP7 Blocking ELISA diagnostic test for African horse sickness.

Authors:  Manuel Durán-Ferrer; Montserrat Agüero; Stephan Zientara; Cécile Beck; Sylvie Lecollinet; Corinne Sailleau; Shirley Smith; Christiaan Potgieter; Paloma Rueda; Patricia Sastre; Federica Monaco; Ruben Villalba; Cristina Tena-Tomás; Carrie Batten; Lorraine Frost; John Flannery; Simon Gubbins; Baratang A Lubisi; José Manuel Sánchez-Vizcaíno; Michelle Emery; Tracy Sturgill; Eileen Ostlund; Javier Castillo-Olivares
Journal:  Transbound Emerg Dis       Date:  2018-08-02       Impact factor: 5.005

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.